Remove Biobanking Remove Medicine Remove Pharma Companies
article thumbnail

Can genetic data be a magic bullet for drug R&D?

pharmaphorum

As part of the US government’s Cancer Moonshot initiative, a Cancer Moonshot Biobank was launched that asked participants to donate biospecimens and associated health information to aid research. The company has received US Food and Drug Administration approval for pharmacogenetic reports to be provided to users based on their genetics.

article thumbnail

Digitalising drug discovery

pharmaphorum

The oceans of health data out there can be overwhelming for pharma companies to manage – but if extracted correctly, the prospect to develop drugs from scratch in as little as a year is very real, says Lifebit CEO, Dr Maria Chatzou Dunford. . According to an article by Stephens, Zachary D., on Big data: astronomical or genomical? ,